Q32 Bio Inc.QTTBNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank18
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P18
Within normal range
vs 5Y Ago
-0.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-46.10%
Q3 202560.29%
Q2 202514.67%
Q1 2025-9.22%
Q4 202441.46%
Q3 202412.12%
Q2 2024-52.66%
Q1 2024-35.80%
Q4 2023-167.39%
Q3 2023625.74%
Q2 2023117.53%
Q1 2023-231.26%
Q4 2022138.18%
Q3 202219.17%
Q2 2022-0.53%
Q1 2022-0.83%
Q4 2021-19.86%
Q3 2021-5.29%
Q2 202119.15%
Q1 2021-156.83%
Q4 202059.80%
Q3 2020-3.22%
Q2 2020-8.28%
Q1 20201.85%
Q4 2019-3.33%
Q3 2019-17.60%
Q2 2019-21.26%
Q1 2019-121.20%
Q4 201840.99%
Q3 2018-40.46%
Q2 201811.74%
Q1 2018-150.09%
Q4 20170.00%
Q3 20170.00%